F.F. Brockschmidt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
F.F. Brockschmidt has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Axel Maximilian Hillmer
Institute of Pathology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany
1 shared publication B. Lippke
Department of Genomics, Life & Brain Center, University of Bonn, Sigmund‐Freud‐Str. 25, D‐53127 Bonn, Germany
1 shared publicationC. Herold
Institute of Medical Biometry, Informatics and Epidemiology, University of Bonn, Bonn, Germany
1 shared publication- Christian Meesters
High Performance Computing Group, University of Mainz, 55131 Mainz, Germany
1 shared publication F.A. Degenhardt
Department of Genomics, Life & Brain Center, University of Bonn, Sigmund‐Freud‐Str. 25, D‐53127 Bonn, Germany
1 shared publication- Holger Fröhlich
Fraunhofer SCAI, Sankt Augustin, Germany
1 shared publication
Latest Publications
- 27 October 2011
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 165 (6) , 1293-1302
Susceptibility variants on chromosome 7p21.1 suggest HDAC9 as a new candidate gene for male-pattern baldness
Background Male‐pattern baldness (androgenetic alopecia, AGA) is the most common form of hair loss among humans. Research has shown that it is caused by genetic factors. Numerous studies have unequivocally identified two major genetic risk loci for AGA: the X‐chromosomal AR/EDA2R locus, and the PAX1/FOXA2 locus on chromosome 20. Objectives To identify further candidate genes for AGA, and thus gain further insights into this phenotype. Methods A German sample of 581 severely affected cases and 617 controls was used to perform a genome‐wide association study. The identified associated locus was further analysed by fine‐mapping, and then independently replicated in an Australian sample. Expression and pathway analyses were performed to characterize the susceptibility gene identified. Results The most significant association signal was obtained for rs756853 (P = 1·64 × 10−7), which is located intronically in the histone deacetylase 9 (HDAC9) gene. Fine‐mapping and a family‐based analysis revealed that rs756853 and the 6‐kb distal rs2249817 were the most highly associated single nucleotide polymorphisms. The association finding was replicated in an independent Australian sample, when the analysis was restricted to severely affected cases and unaffected controls (P = 0·026). Analysis of rs2249817 in a combined sample of severely affected German and Australian cases and unaffected controls revealed a strong association signal (P = 9·09 × 10−8). Tissue expression studies demonstrated HDAC9 expression in various tissues, including tissues of relevance to AGA. No strong genotypic effects were observed in genotype‐specific expression or splice studies. Pathway analyses supported the hypothesis that HDAC9 plays a functional role in AGA via interaction with the AR gene. Conclusions The present study suggests that HDAC9 is the third AGA susceptibility gene.
- 27 October 2011
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 165 (6) , 1293-1302
Susceptibility variants on chromosome 7p21.1 suggest HDAC9 as a new candidate gene for male-pattern baldness
Background Male‐pattern baldness (androgenetic alopecia, AGA) is the most common form of hair loss among humans. Research has shown that it is caused by genetic factors. Numerous studies have unequivocally identified two major genetic risk loci for AGA: the X‐chromosomal AR/EDA2R locus, and the PAX1/FOXA2 locus on chromosome 20. Objectives To identify further candidate genes for AGA, and thus gain further insights into this phenotype. Methods A German sample of 581 severely affected cases and 617 controls was used to perform a genome‐wide association study. The identified associated locus was further analysed by fine‐mapping, and then independently replicated in an Australian sample. Expression and pathway analyses were performed to characterize the susceptibility gene identified. Results The most significant association signal was obtained for rs756853 (P = 1·64 × 10−7), which is located intronically in the histone deacetylase 9 (HDAC9) gene. Fine‐mapping and a family‐based analysis revealed that rs756853 and the 6‐kb distal rs2249817 were the most highly associated single nucleotide polymorphisms. The association finding was replicated in an independent Australian sample, when the analysis was restricted to severely affected cases and unaffected controls (P = 0·026). Analysis of rs2249817 in a combined sample of severely affected German and Australian cases and unaffected controls revealed a strong association signal (P = 9·09 × 10−8). Tissue expression studies demonstrated HDAC9 expression in various tissues, including tissues of relevance to AGA. No strong genotypic effects were observed in genotype‐specific expression or splice studies. Pathway analyses supported the hypothesis that HDAC9 plays a functional role in AGA via interaction with the AR gene. Conclusions The present study suggests that HDAC9 is the third AGA susceptibility gene.